Meton Pharmaceuticals Co., LTD., established in 2015 and basing in Shanghai, China, is dedicated to innovative (first-in-class) drug discovery. Benefiting from the long-time research experience of our scientists in cancer metabolism, Meton’s current R&D strategy is to target tumor-related metabolic enzymes for potential therapeutic solutions. We have built up a comprehensive discovery platform and our team with professional expertise is keeping all projects advancing in fast track. So far, all two projects are on the way from lead optimization to PCC. Innovative, original R&D in compliance with law and regulation are believed to embody our values and fulfill our visions.
迈同公司启航2018年,继续前行、探索和成长!上海迈同生物科技有限公司是一家致力于开发靶向肿瘤治疗新药的高科技创新型企业。